Eli Lilly hikes Mounjaro prices in the UK
Digest more
In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that it helped people lower their weight by an average of 12% after 72 weeks.
Asda Online Doctor said it had seen a 350 per cent increase in demand for Mounjaro since Lilly announced the price rise on Thursday, while London-based MedExpress said it had seen a 40 per cent jump in orders, compared with a normal day. MedExpress’s website slowed as customers rushed to buy the drug, because of the “significant uptick in traffic”.